chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza like illness, Migraine, Myalgia, Nausea
Clinical narrative: Still experiencing severe muscle pain in right leg and left arm (arm was vax site); Severe migraine; Flu-like symptoms; Diarrhea; Nausea; Temperature regulation issues; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533) via an unspecified route of administration in the left arm on 04Apr2021 at 17:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Information on medical history and known allergies was not available. Information on whether the patient had received any other medications in two weeks was not available. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6203) via an unspecified route of administration in the left arm on 13Mar2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 08:00 the patient was still experiencing severe muscle pain in his right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe muscle pain in right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Temperature regulation disorder
Clinical narrative: Still experiencing severe muscle pain in right leg and left arm (arm was vax site); Severe migraine; Flu-like symptoms; Diarrhea; Nausea; Temperature regulation issues; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533) via an unspecified route of administration in the left arm on 04Apr2021 at 17:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Information on medical history and known allergies was not available. Information on whether the patient had received any other medications in two weeks was not available. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6203) via an unspecified route of administration in the left arm on 13Mar2021 at 13:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 08:00 the patient was still experiencing severe muscle pain in his right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe muscle pain in right leg and left arm (arm was vax site), severe migraine, flu-like symptoms, diarrhea, nausea, and temperature regulation issues was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Ear swelling, Pruritus, Rash vesicular
Clinical narrative: red rash with bumps and some small blisters on right side of face near lips, chin left side, up across the left cheek, left ear, and part of the neck; Feels slight burning; Itch; Left ear lope got very swollen; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: EN6204) via an unspecified route of administration in the right arm on 23Mar2021 at 12:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), testosterone (MANUFACTURER UNKNOWN) sustained-release and estradiol, estriol (BI EST), all for unknown indications from unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021, the patient had rash on face, that started on right side near lips and spread to the chin to the left side and up across the left cheek and to the left ear and then part of the neck. The rash was red with bumps and some small blisters. The patient felt slight burning and itch. The patient had very swollen left ear lope. The events lasted for 6 or more days. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events red rash with bumps and some small blisters on right side of face near lips, chin left side, up across the left cheek, left ear, and part of the neck, felt slight burning, itch and left ear lope got very swollen were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia, Pain in extremity, Paraesthesia, Peripheral swelling
Clinical narrative: Numbness in hands and feet; Tingling in hands and feet; Pain in hands; Redness in hands; Swelling in hands; This is a spontaneous report from a contactable other healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 09Jan2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine hydrochloride (CYMBALTA) taken from an unknown date for an unknown indication and birth control pill (MANUFACTURER UNKNOWN) taken from an unknown date. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 19Dec2020 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 25Mar2021 at 13:00 the patient experienced numbness and tingling in hands and feet 3 months later. The patient also experienced pain in hands, redness in hands and swelling in hands on 25Mar2021 at 13:00. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. Therapeutic measures included intake of naproxen for the reported events. The clinical outcome of the events numbness and tingling in hands and feet, pain in hands, redness in hands and swelling in hands were not resolved at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Grip strength decreased, Hypoaesthesia, Muscular weakness, Paraesthesia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 13:15 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 01:00 the patient experienced pins and needles in her fingers and her hands. When she woke up on 03Apr2021 the problem persisted, and she also began to feel weakness and numbness in her hands. It was difficult to grip things, and at night she began to feel pins and needles in her feet, arms, and shoulders. On 04Apr2021 the problem still persisted, although she felt less of a tingling sensation in her shoulders. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event pins and needles in fingers and hands/pins and needles in feet, arms and shoulders/tingling sensation in shoulders, weakness in hands, numbness in hands and difficulty to grip things was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Pain in all joints in my left arm started about 1-2 hours after receiving injection. Joints: Shoulder, elbow, wrist and hands. Obviously pain in the muscle where I received the injection but thats exp; pain in the muscle where I received the injection; This is a spontaneous report from a contactable nurse, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via intramuscular route of administration in the left arm on 05Apr2021 (At the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 11:00 the patient experienced pain in all joints in left arm started about 1-2 hours after receiving injection. Joints: Shoulder, elbow, wrist and hands. Obviously pain in the muscle where she received the injection but that was expected with any intramuscular injection. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events joint pain, muscle pain was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Epistaxis, Nausea
Clinical narrative: Abdominal pain; Diarrhea; Nose bleeds that took a long time to stop and that were quite heavy; Intense nausea; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via unspecified route of administration in the left arm on 04Apr2021 at 13:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, functional dyspepsia, anxiety, depression, obsessive-compulsive disorder (OCD) and emetophobia. The patient was allergic to tree nuts. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) on an unknown date and for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 11:30, 24 hours after the vaccination, patient had diarrhea and further experienced multiple nose bleeds that took a long time to stop and were quite heavy, intense nausea and abdominal pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events multiple nose bleeds, intense nausea, abdominal pain and diarrhea were resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Lymphadenopathy, Myalgia, Oropharyngeal pain
Clinical narrative: Sore throat; Muscle aches; Joint pain; Febrile; Swollen lymph node in armpit; Cough; This is a spontaneous report from a contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Mar2021 at 15:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin, ibuprofen, bactrim and propofol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 16:30, after 1485 minutes of the vaccination, the patient experienced sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit of arm shot was given in and cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit and cough was resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sore throat; Muscle aches; Joint pain; Febrile; Swollen lymph node in armpit; Cough; This is a spontaneous report from a contactable other healthcare professional, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Mar2021 at 15:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin, ibuprofen, bactrim and propofol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 at 16:30, after 1485 minutes of the vaccination, the patient experienced sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit of arm shot was given in and cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore throat, muscle aches, joint pain, febrile, swollen lymph node in armpit and cough was resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Dizziness, Nausea, Pain
Clinical narrative: lightheaded; extreme stomach pains; low grade fever; chills; body aches; full blown nausea; dizziness; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and penicillin allergy. Concomitant medications included olmesartan (MANUFACTURER UNKNOWN) and chlortalidone (CHLORTHALIDONE) all from an unknown date for unspecified indication. The patient previously took first dose of  BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 at 10:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 02:00, the patient experienced low grade fever, chills, body aches. Woke up from sleep with full blown nausea, dizziness, lightheaded with extreme stomach pains. Symptoms have continued for the last 8 days since getting second vaccine. Visited medical provider on 05Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with meclizine 12.5 mg / blood work. The clinical outcome of the events low grade fever, chills, body aches, full blown nausea, dizziness, lightheaded and extreme stomach pains was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: lightheaded; extreme stomach pains; low grade fever; chills; body aches; full blown nausea; dizziness; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and penicillin allergy. Concomitant medications included olmesartan (MANUFACTURER UNKNOWN) and chlortalidone (CHLORTHALIDONE) all from an unknown date for unspecified indication. The patient previously took first dose of  BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 at 10:15 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 02:00, the patient experienced low grade fever, chills, body aches. Woke up from sleep with full blown nausea, dizziness, lightheaded with extreme stomach pains. Symptoms have continued for the last 8 days since getting second vaccine. Visited medical provider on 05Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with meclizine 12.5 mg / blood work. The clinical outcome of the events low grade fever, chills, body aches, full blown nausea, dizziness, lightheaded and extreme stomach pains was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pain, Pyrexia
Clinical narrative: Fever 99.5; Chills; Vomiting; Nausea; Pain at injection site; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease stage 3 (Ckd stage 3), non-alcoholic fatty liver, tachycardia, adrenal insufficiency from unilateral adrenalectomy. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications taken within two weeks prior to vaccination included lisinopril (MANUFACTURER UNKNOWN), carvedilol (COREG), montelukast sodium (SINGULAIR), hydrochlorothiazide (MANUFACTURER UNKNOWN), omeprazole (PROZA), all for unknown indication from unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 14Mar2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced fever 99.5 (unspecified units), chills, vomiting, nausea, pain at injection site and body aches. Therapeutic measures were taken as a result of nausea for which the doctor called in antinausea medication. The adverse events fever 99.5 (unspecified units), chills, vomiting, pain at injection site and body aches did not result in doctor or other healthcare professional office/clinic visit/emergency visit. The clinical outcome of the events fever 99.5, chills, vomiting, nausea, pain at injection site and body aches was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: Fever 99.5; Chills; Vomiting; Nausea; Pain at injection site; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic kidney disease stage 3 (Ckd stage 3), non-alcoholic fatty liver, tachycardia, adrenal insufficiency from unilateral adrenalectomy. The patient had previously taken penicillin and experienced penicillin allergy. Concomitant medications taken within two weeks prior to vaccination included lisinopril (MANUFACTURER UNKNOWN), carvedilol (COREG), montelukast sodium (SINGULAIR), hydrochlorothiazide (MANUFACTURER UNKNOWN), omeprazole (PROZA), all for unknown indication from unknown date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 14Mar2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:00, the patient experienced fever 99.5 (unspecified units), chills, vomiting, nausea, pain at injection site and body aches. Therapeutic measures were taken as a result of nausea for which the doctor called in antinausea medication. The adverse events fever 99.5 (unspecified units), chills, vomiting, pain at injection site and body aches did not result in doctor or other healthcare professional office/clinic visit/emergency visit. The clinical outcome of the events fever 99.5, chills, vomiting, nausea, pain at injection site and body aches was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pyrexia
Clinical narrative: Severe congestion; Fever; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EX16205) via an unspecified route of administration in the left arm on 30Mar2021 at 08:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included hypothyroidism. The patient did not have any allergies to food, medications, or other products. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) 75 mcg from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 13:00, the patient experienced severe congestion, sore throat and fever. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events congestion, fever and sore throat was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Fatigue, Hypersensitivity, Hypoaesthesia oral
Clinical narrative: Mild allergic reaction; Itching at injection site; Itching throughout the body; body aches; Chills; fatigue; Slight metallic taste; Numbing sensation on tongue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 02Apr2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), diabetes, non-alcoholic steatohepatitis (NASH), overweight and COVID-19. Concomitant medications included telmisartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN),  metformin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (CETRIZINE)  and folic acid (MANUFACTURER UNKNOWN) all for unspecified indication started from an unknown date. The patient previously took fenofibrate (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously took prednisone (MANUFACTURER UNKNOWN) and experienced strong reaction (unspecified) to methyl-prednisone. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, minutes after the vaccination, the patient experienced slight metallic taste and numbing sensation on tongue. On 03Apr2021, the patient experienced body aches, chills, fatigue. On 04Apr2021 at 16:00, the patient experienced mild allergic reaction and itching at injection and itching throughout the body. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste and numbing sensation on tongue was recovered on 02Apr2021 ; while that of body aches, chills and fatigue was recovered on an unknown date in Apr2021. The clinical outcome of events itching at injection site, itching throughout the body was recovering; while that of  mild allergic reaction was not recovered.      No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Vaccination site pruritus
Clinical narrative: Mild allergic reaction; Itching at injection site; Itching throughout the body; body aches; Chills; fatigue; Slight metallic taste; Numbing sensation on tongue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 02Apr2021 at 11:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), diabetes, non-alcoholic steatohepatitis (NASH), overweight and COVID-19. Concomitant medications included telmisartan (MANUFACTURER UNKNOWN), atenolol (MANUFACTURER UNKNOWN),  metformin (MANUFACTURER UNKNOWN), cetirizine hydrochloride (CETRIZINE)  and folic acid (MANUFACTURER UNKNOWN) all for unspecified indication started from an unknown date. The patient previously took fenofibrate (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously took prednisone (MANUFACTURER UNKNOWN) and experienced strong reaction (unspecified) to methyl-prednisone. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, minutes after the vaccination, the patient experienced slight metallic taste and numbing sensation on tongue. On 03Apr2021, the patient experienced body aches, chills, fatigue. On 04Apr2021 at 16:00, the patient experienced mild allergic reaction and itching at injection and itching throughout the body. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste and numbing sensation on tongue was recovered on 02Apr2021 ; while that of body aches, chills and fatigue was recovered on an unknown date in Apr2021. The clinical outcome of events itching at injection site, itching throughout the body was recovering; while that of  mild allergic reaction was not recovered.      No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Illness, Muscle fatigue, Nausea, Pyrexia
Clinical narrative: Extreme nausea; Vomiting; Stomach pain; Ringing in ears; Fever; Extreme muscle fatigue; Still sick; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 08:15 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, the patient experienced extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the events extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vomiting
Clinical narrative: Extreme nausea; Vomiting; Stomach pain; Ringing in ears; Fever; Extreme muscle fatigue; Still sick; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 08:15 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 15:00, the patient experienced extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcomes of the events extreme nausea, vomiting, stomach pain, ringing in ears, fever, extreme muscle fatigue and still sick 5 days later were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness, Dysgeusia, Fatigue, Headache
Clinical narrative: Metallic taste; heightened dizziness; Stomach upset; pain; exhaustion; headache; This is a spontaneous report from a contactable consumer. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, benign essential tremor, osteoarthritis. The patient previously received codeine phosphate (CODEINE) for unknown indication on an unknown date and experienced drug allergy. It was unknown if the patient  was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), curcuma longa root (TURMERIC) and paracetamol (TYLENOL) started from unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 13:00 the patient experienced metallic taste, heightened dizziness,  stomach upset, pain, exhaustion and headache. The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events metallic taste, heightened dizziness, stomach upset, pain, exhaustion and headache was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Metallic taste; heightened dizziness; Stomach upset; pain; exhaustion; headache; This is a spontaneous report from a contactable consumer. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, benign essential tremor, osteoarthritis. The patient previously received codeine phosphate (CODEINE) for unknown indication on an unknown date and experienced drug allergy. It was unknown if the patient  was diagnosed with COVID-19, prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), curcuma longa root (TURMERIC) and paracetamol (TYLENOL) started from unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 13:00 the patient experienced metallic taste, heightened dizziness,  stomach upset, pain, exhaustion and headache. The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events metallic taste, heightened dizziness, stomach upset, pain, exhaustion and headache was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Lip swelling, Pain, Pyrexia
Clinical narrative: Woke up and my lips werecompletely swollen, I have had fillersin the past. Very painful experience forme; Fevers; Tons of pain; I was very sick the first night; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 03Apr2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to nuts (allergic to cashews and pistachios) and COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), fish oil (MANUFACTURER UNKNOWN) and b vitamins (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 16:00, the patient was very sick the first night, fevers with tons of pain. On 05Apr2021, on Monday morning, the patient woke up and lips were completely swollen, the patient had fillers in the past and had a very painful experience. The events resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of events and included treatment with benadryl and steroid. The clinical outcome of the events pain, sickness, swollen lips and fevers were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus, high pitch frequency sound inboth ears; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old, male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route in left arm on 21Mar2021 (at an age of 66-years-old) as single dose for COVID-19 immunisation. The medical history of patient was reported as none. The patient had no allergies to medications, food, or other products.The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route in left arm on 20Feb2021 (at the age of 66-years-old) as single dose for COVID-19 immunisation. The patient received citalopram (MANUFACTURERS UNKNOWN) and simvastatin (MANUFACTURERS UNKNOWN) started on an unknown date within 2 weeks prior to the COVID vaccine for unknown indications. Prior to the vaccination the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID vaccine. On 23Mar2021, the patient had tinnitus, high pitch frequency sound in both ears. No treatment was given for the event. The clinical outcome of the event was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test
Clinical narrative: Rash break out on both forearms, just above and below both knees in the back of both leg; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021(at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 from unknown date. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), tizanidine (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) and ga (as reported); all for unspecified indication and from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, the patient experienced rash break out on both forearms, just above and below both knees in the back of both legs. The patient underwent lab tests and procedures which included polymerase chain reaction test on 30Mar2021 and tested negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event rash on legs and arm was not recovered at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Pain in extremity
Clinical narrative: Slightly reduced range of motion in arm.; Slight soreness in vaccinated arm; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7533), via an unspecified route of administration in the right arm on 04Apr2021 at 12:45 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history and other allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 18:30, the patient experienced slight soreness in vaccinated arm and slightly reduced range of motion in arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events slight soreness in vaccinated arm and slightly reduced range of motion in arm were recovered on an unspecified date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site discomfort, Vaccination site pain
Clinical narrative: significant discomfort in the injection area; soreness injection site; This is a spontaneous report from a contactable consumer. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 10:30 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroidism and blood pressure high. Patient previously received sulfamethoxazole for an unknown indication on an unknown date and experienced drug allergy. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), SYNTHROID, ezetimibe (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN), all for unknown indications from an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient underwent nasal swab test and the result was negative. On 20Mar2021, the patient experienced vaccination site discomfort and vaccination site soreness. Its reported that  approximately 24 hours after the initial vaccine was administered patient experienced significant discomfort in the injection area that had been increasingly worse and sustained since the administration date with no improvement in discomfort and soreness. The events resulted in doctor or other healthcare professional office/clinic visit (discussed with pcp). The clinical outcome of the events of vaccination site discomfort and vaccination site pain were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain, Lymphadenopathy, Pain in extremity, Renal pain
Clinical narrative: Kidney pain; Jaw lymph nodes swelling; Jaw lymph nodes pain; Fatigue; Injection arm pain; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received unknown dose of  BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, asthma, high bp (blood pressure high), obese (obesity), arthritis and disc problems. The patient received many unspecified medications within two weeks of vaccination. The patient previously took sulfa (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy on unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:00 the patient experienced kidney pain, jaw lymph nodes swelling (swollen lymph nodes) and pain (lymph nodes pain), fatigue and injection arm pain (pain in arm). The patient did not receive any treatment for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events kidney pain, jaw lymph nodes swelling, jaw lymph nodes pain, fatigue and injection arm pain were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.